Baptista Marco A S, Martin-Fardon Rémi, Weiss Friedbert
Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California 92037, USA.
J Neurosci. 2004 May 19;24(20):4723-7. doi: 10.1523/JNEUROSCI.0176-04.2004.
Metabotropic glutamate receptors (mGluRs) have been implicated in regulating anxiety, stress responses, and the neurobehavioral effects of psychostimulants. The present study sought to determine whether group II mGluR activation by the potent mGlu2/3 receptor agonist, (-)-2-oxa-4-aminobicylco hexane-4,6-dicarboxylic acid (LY379268), antagonizes reinstatement of cocaine-seeking induced by cocaine-related stimuli and whether this effect extends to behavior induced by stimuli conditioned to a potent conventional reinforcer, sweetened condensed milk (SCM). Also, we tested whether the suppressant effects of LY379268 on conditioned reinstatement extend to the primary reinforcing effects of cocaine or SCM. Rats were trained to associate discriminative stimuli (S(D)) with the availability of cocaine or SCM versus non-reward and then subjected to repeated extinction sessions during which the respective reinforcers and S(D) were withheld. Subsequent reexposure to the cocaine or SCM S(D), but not the non-reward S(D), produced recovery of responding at the previously active lever. LY379268 (0.3-3.0 mg/kg, s.c.) dose-dependently attenuated recovery of cocaine seeking but reduced conditioned reinstatement by the SCM S(D) only at the highest dose. LY379268 did not alter responding reinforced directly by SCM, and only the highest LY379268 dose reduced cocaine self-administration. The results suggest that the effects of LY379268 are selective for behavior maintained by cocaine as opposed to palatable conventional reinforcers. More importantly, the results show that LY379268 suppresses behavior motivated by stimuli conditioned to cocaine or SCM more effectively than consummatory behavior maintained by the unconditioned effects of these substances. As such, the results identify group II mGluRs as a pharmacotherapeutic target for craving and relapse prevention associated with cocaine cue exposure.
代谢型谷氨酸受体(mGluRs)与调节焦虑、应激反应以及精神兴奋剂的神经行为效应有关。本研究旨在确定强效mGlu2/3受体激动剂(-)-2-氧杂-4-氨基双环[3.1.0]己烷-4,6-二羧酸(LY379268)激活II组mGluR是否能拮抗由可卡因相关刺激诱导的可卡因觅求行为的恢复,以及这种效应是否扩展到由与强效传统强化物甜炼乳(SCM)相关的刺激所诱导的行为。此外,我们还测试了LY379268对条件性恢复的抑制作用是否扩展到可卡因或SCM的初级强化作用。大鼠接受训练,将辨别性刺激(S(D))与可卡因或SCM的可得性以及无奖励情况联系起来,然后进行重复的消退训练,在此期间,分别 withheld强化物和S(D)。随后再次暴露于可卡因或SCM的S(D),而不是无奖励的S(D),导致在先前活跃的杠杆上反应恢复。LY379268(0.3 - 3.0毫克/千克,皮下注射)剂量依赖性地减弱可卡因觅求行为的恢复,但仅在最高剂量时降低SCM的S(D)诱导的条件性恢复。LY379268不改变由SCM直接强化的反应,并且只有最高剂量de LY379268降低可卡因自我给药。结果表明,LY379268的作用对由可卡因维持的行为具有选择性,而不是对美味的传统强化物。更重要的是,结果表明LY379268比由这些物质的非条件作用维持的满足行为更有效地抑制由与可卡因或SCM相关的刺激所激发的行为。因此,结果确定II组mGluR是与可卡因线索暴露相关的渴望和复发预防的药物治疗靶点。